Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma

HPB

Volumn 15, Issue 7, 2013, Pages 504-510

  Mathur, Abhishek ^a   Franco, Edson S ^a   Leone, John P ^a   Osman Mohamed, Hussein ^a   Rojas, Haydy ^a   Kemmer, Nyingi ^a   Neff, Guy W ^a   Rosemurgy, Alexander S ^a   Alsina, Angel E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CANCER RECURRENCE; CANCER SURVIVAL; DEMOGRAPHY; DISEASE MARKER; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; ANALYSIS OF VARIANCE; INCIDENCE; KAPLAN MEIER METHOD; LENGTH OF STAY; LIVER TUMOR; MORTALITY; PATHOLOGY; RISK FACTOR; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; CARCINOMA, HEPATOCELLULAR; COMPLICATION; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS;

ANALYSIS OF VARIANCE; BODY MASS INDEX; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBESITY; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84888055339     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00602.x     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J, Pisani P. (2001) Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 94:153-156.
2. Altekruse SF, McGlynn KA, Reichman ME. (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27:1485-1491.
3. Yao FY, Bass NM, Ascher NL, Roberts JP. (2004) Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-stage Liver Disease (MELD) organ allocation policy. Liver Transpl 10:621-630.
4. Flegal KM, Carroll MD, Ogden CL, Johnson CL. (2002) Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288:1723-1727.
5. World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation.World Health Organ Tech Rep Ser 894:1-253.
6. Nair S, Verma S, Thuluvath PJ. (2000) Obesity and its effect on survival in patients undergoing OLT in the United States. Hepatology 35:105-109.
7. International Agency for Research on Cancer Working Group on Evaluation of Cancer-Preventive Strategies. (2002) Weight Control and Physical Activity. Lyon: IARC Press.
8. Mathur A, Hernandez J, Shaheen F, Shroff M, Dahal S, Morton C et al. (2011) Preoperative computed tomography measurements of pancreatic steatosis and visceral fat: prognostic markers for dissemination and lethality of pancreatic adenocarcinoma. HPB 13:404-410.
9. Mathur A, Zyromski NJ, Pitt HA, Al-Azzawi H, Walker JJ, Saxena R et al. (2009) Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg 208:989-994; discussion 994-996.
10. Flancbaum L, Choban PS. (1998) Surgical implications of obesity. Annu Rev Med 49:15-34.
11. Choban PS, Flancbaum L. (1997) The impact of obesity on surgical outcome: a review. J Am Coll Surg 185:593-603.
12. Dindo D, Demartines N, Clavien PA. (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213.
13. Nair S, Eustace J, Thuluvath PJ. (2002) Effect of race on outcome of OLT: a cohort study. Lancet 26:287-293.
14. Thuluvath PJ, Yoo HY, Thompson RE. (2003) A model to predict survival at one month, one year, and five years after liver transplantation based on pre-transplant clinical characteristics. Liver Transpl 9:527- 532.
15. Nair S, Cohen DB, Cohen MP, Tan H, Maley W, Thuluvath PJ. (2001) Postoperative morbidity, mortality, costs, and longterm survival in severely obese patients undergoing OLT. Am J Gastroenterol 96:842- 845.
16. Keeffe EB, Gettys C, Esquivel CO. (1994) Liver transplantation in patients with severe obesity. Transplantation 57:309-311.
17. Sawyer RG, Pelletier SJ, Pruett TL. (1999) Increased early morbidity and mortality with acceptable longterm function in severely obese patients undergoing liver transplantation. Clin Transplant 13:126-130.
18. Braunfeld MY, Chan S, Pregler J, Neelakanta G, Sopher MJ, Busuttil RW et al. (1996) Liver transplantation in obese patients. J Clin Anesth 8:585- 590.
19. Schaeffer DF, Yoshida EM, Buczkowski AK, Chung SW, Steinbrecher UP, Erb SE et al. (2009) Surgical morbidity in severely obese liver transplant recipients - a single Canadian centre experience. Ann Hepatol 8:38-40.
20. Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ. (2003) The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 21:4329-4335.
21. Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, Hong J et al. (2008) Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg 143:182-188.
22. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699.
23. Marsh JW, Dvorchik I, Subotin M, Balan V, Rakela J, Popechitelev EP et al. (1997) The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after OLT: a pilot study. Hepatology 26:444- 450.
24. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R Jr, Kerlan R et al. (2005) The impact of preoperative locoregional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 5:795-804.
25. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S et al. (1991) Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214:221-228.
26. Greenberg AS, Obin MS. (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83 (Suppl.):461-465.
27. Juge-Aubry CE, Henrichot E, Meier CA. (2005) Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 19:547-566.
28. Garofalo C, Surmacz E. (2006) Leptin and cancer. J Cell Physiol 207:12- 22.
29. Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M et al. (2000) Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide3-kinase-, rho, and rac-dependent signalling pathways. FASEB J 14:2329-2338.
30. Sweeney G. (2002) Leptin signalling. Cell Signal 14:655-663.
31. Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D et al. (2007) Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signalling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 67:2497-2507.
32. Chen C, Chang YC, Liu CL, Liu TP, Chang KJ, Guo IC. (2007) Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by upregulating cyclin D1 and downregulating Bax via a Janus kinase 2-linked pathway. Endocr Relat Cancer 14:513-529.
33. Ribatti D, Belloni AS, Nico B, Di Comite M, Crivellato E, Vacca A. (2008) Leptin-leptin receptor are involved in angiogenesis in human hepatocellular carcinoma. Peptides 29:1596-1602.
34. Stefanou N, Papanikolaou V, Furukawa Y, Nakamura Y, Tsezou A. (2010) Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. BMC Cancer 10:442.
35. Sharma D, Wang J, Fu PP, Sharma S, Nagalingam A, Mells J et al. (2010) Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology 52:1713-1722.
36. Allen JG, Arnaoutakis GJ, Weiss ES, Merlo CA, Conte JV, Shah AS. (2010) The impact of recipient body mass index on survival after lung transplantation. J Heart Lung Transplant 29:1026-1033.
37. Gore JL, Pham PT, Danovitch GM, Wilkinson AH, Rosenthal JT, Lipshutz GS et al. (2006) Obesity and outcome following renal transplantation. Am J Transplant 6:357-363.